Cargando…

The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1a(Cre/+);LSL-Kras(G12D/+) transgenic mouse model of pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading forms of cancer related deaths in the United States. With limited treatment options and unreliable diagnostic methods, long-term survival rates following a diagnosis of pancreatic cancer remain poor. Pancreatic intraepithelial neoplasia (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veite-Schmahl, Michelle J., Rivers, Adam C., Regan, Daniel P., Kennedy, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679567/ https://www.ncbi.nlm.nih.gov/pubmed/29121082 http://dx.doi.org/10.1371/journal.pone.0187552

Ejemplares similares

HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer
por: Veite-Schmahl, Michelle J, et al.
Publicado: (2017)

NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer
por: Schmahl, Michelle J., et al.
Publicado: (2018)

LSL-Kras(G12D); LSL-Trp53(R172H/+); Ink4(flox/+); Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
por: Ma, Lixiang, et al.
Publicado: (2017)

Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐Kras(G12D)) mice
por: Yu, Wei, et al.
Publicado: (2021)

Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
por: Liot, Sophie, et al.
Publicado: (2021)

Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
por: Carneiro, Tatiana J., et al.
Publicado: (2022)

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras(G12D/+);Tp53(R172H/+) (KPC) mice, a genetically engineered model of pancreatic cancer
por: Vilimas, Tomas, et al.
Publicado: (2018)

Zebrafish model of KRAS-initiated pancreatic cancer
por: Park, Joon Tae, et al.
Publicado: (2018)

Conditional Gene Targeting in Mouse Pancreatic β-Cells: Analysis of Ectopic Cre Transgene Expression in the Brain
por: Wicksteed, Barton, et al.
Publicado: (2010)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model
por: Delahoussaye, Abagail M., et al.
Publicado: (2022)

PTF1a Activity in Enriched Posterior Foregut Endoderm, but Not Definitive Endoderm, Leads to Enhanced Pancreatic Differentiation in an In Vitro Mouse ESC-Based Model
por: Nair, Gopika G., et al.
Publicado: (2016)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Isolated Pancreatic Aplasia Due to a Hypomorphic PTF1A Mutation
por: Houghton, Jayne A.L., et al.
Publicado: (2016)

Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer
por: Cao, Zhu Alexander, et al.
Publicado: (2002)

Tissue and Serum microRNAs in the Kras(G12D) Transgenic Animal Model and in Patients with Pancreatic Cancer
por: LaConti, Joseph J., et al.
Publicado: (2011)

Tamoxifen affects chronic pancreatitis‐related fibrogenesis in an experimental mouse model: an effect beyond Cre recombination
por: Li, Xuan, et al.
Publicado: (2019)

Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model
por: Mahato, Ram, et al.
Publicado: (2023)

Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered Kras(G12D);Pdx1-Cre mouse (KC) model
por: Rachagani, Satyanarayana, et al.
Publicado: (2015)

Extracellular acidosis differentiates pancreatitis and pancreatic cancer in mouse models using acidoCEST MRI
por: High, Rachel A., et al.
Publicado: (2019)

Innervated mouse pancreas organoids as an ex vivo model to study pancreatic neuropathy in pancreatic cancer
por: Besikcioglu, H. Erdinc, et al.
Publicado: (2021)

Characterization of genetic subclonal evolution in pancreatic cancer mouse models
por: Niknafs, Noushin, et al.
Publicado: (2019)

Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
por: Saiki, Yuriko, et al.
Publicado: (2021)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023)

KRAS drives immune evasion in a genetic model of pancreatic cancer
por: Ischenko, Irene, et al.
Publicado: (2021)

Reduction of Ptf1a Gene Dosage Causes Pancreatic Hypoplasia and Diabetes in Mice
por: Fukuda, Akihisa, et al.
Publicado: (2008)

The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma
por: Krah, Nathan M, et al.
Publicado: (2015)

The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine
por: Chen, Shan-Ming, et al.
Publicado: (2020)

KRAS above and beyond – EGFR in pancreatic cancer
por: Siveke, Jens T., et al.
Publicado: (2012)

Beyond Kras: MYC Rules in Pancreatic Cancer
por: Korc, Murray
Publicado: (2018)

Addition of metabolomics to the omics spectrum for cancer biomarker development– demonstration with the KrasG12D mouse model for pancreatic carcinoma
por: Laiakis, Evagelia C, et al.
Publicado: (2014)

Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
por: Chen, Ke, et al.
Publicado: (2017)

Notch1 Deficiency Induces Tumor Cell Accumulation Inside the Bronchiolar Lumen and Increases TAZ Expression in an Autochthonous Kras (LSL-G12V) Driven Lung Cancer Mouse Model
por: Meder, Lydia, et al.
Publicado: (2021)

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
por: Lemstrova, Radmila, et al.
Publicado: (2017)

Induction and characterization of pancreatic cancer in a transgenic pig model
por: Boas, F. Edward, et al.
Publicado: (2020)

Methods of a New Chronic Pancreatitis and Spontaneous Pancreatic Cancer Mouse Model Using Retrograde Pancreatic Duct Injection of Dibutyltin Dichloride
por: Zhang, Deyu, et al.
Publicado: (2022)

Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer
por: Snyder, Cynthia S, et al.
Publicado: (2009)

A modular and flexible ESC-based mouse model of pancreatic cancer
por: Saborowski, Michael, et al.
Publicado: (2014)

Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer
por: Polasek, Miloslav, et al.
Publicado: (2017)

Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
por: Cáceres, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_heerj51rgl5g77tdig7sifkeg0